Last year’s shakeup and mea culpa at San Diego’s Acadia Pharmaceuticals (NASDAQ: ACAD) has paid off. The FDA said late today it has approved Acadia’s pimavanserin (Nuplazid), a treatment for psychosis associated with Parkinson’s disease.
Acadia stumbled badly last year,... Read more »
Cybersecurity is a rapidly changing field. The arms race between hackers and organizations trying to defend themselves has given rise to a lexicon of epic proportions—and leaders from almost every industry are learning to speak the language.
As concepts like antivirus... Read more »
Carving out time to really ponder the future of our technology landscape can be touch, but it can also be incredibly valuable. And if that time is spent with some of the world’s great innovators, technologists, and investors, all the better.... Read more »
As a broker, trader, and hedge fund manager, Howard Lindzon has long been fascinated by the potential use of social media for collecting and sharing stock tips and related information.
He co-founded StockTwits in 2008 as an online social media network... Read more »
Agricultural technology startups face challenges finding the capital to scale their companies, but they also struggle to find the farmland to test their products. Two companies experienced in agricultural investments have come together to launch a new venture fund that they... Read more »
The electric grid we have today operates largely as it has for decades—electricity produced and dispatched across power lines is used by customers right away. But nearly 30 years ago, a tiny North Carolina electric cooperative did something no other electric... Read more »
The biggest biomedical news on this coast, that coast, or any coast this week is the death of Prince Rogers Nelson, 57, a man who did more to promote cardiovascular fitness than any drug maker could ever hope to do. How... Read more »
It doesn’t seem to matter where you live, what you do, or what industry your company is in—the likelihood of a cyber attack is growing, and protecting yourself is ever more front of mind.
Xconomy’s editors around the United States have... Read more »
A little over a year ago, John Qualls, a veteran entrepreneur and leader in the Indianapolis area’s business community, decided to try something slightly different for his next career move.
At the time Qualls was working as an executive at BlueLock,... Read more »
By 2029, more than 20 percent of people in the United States will be over the age of 65. That’s why the race to find effective treatments for Alzheimer’s disease feels urgent. A few drugs, approved well over a decade ago,... Read more »